Jove
Visualize
お問い合わせ

関連する概念動画

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
Kubler Ross's Stages of Dying01:21

Kubler Ross's Stages of Dying

1.0K
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
1.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
Actuarial Approach01:20

Actuarial Approach

276
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
276
Life Tables01:22

Life Tables

472
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
472
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

209
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
209

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same authorSame journal

[Clinical trial or ″regular clinical practice″? The trasmetir study example].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2026
Same author

Genetic Features of Tumours Arising in the Context of Suspected Hereditary Cancer Syndromes with <i>RAD50</i>, <i>RAD51C/D</i>, and <i>BRIP1</i> Germline Mutations, Results of NGS-Reanalysis of BRCA/MMR-Negative Families.

Genes·2025
Same author

[Bioethical issues of Covid-19 in Spain. A systematic review].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2024
Same author

[25 Years from Di Bella affair: what ethical lessons does it leave us?]

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2023
Same author

The Use of Humor in Palliative Care: A Systematic Literature Review.

The American journal of hospice & palliative care·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jan 8, 2026

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
10:08

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans

Published on: May 18, 2022

3.9K

75歳で死ぬ準備はできていますか?

Álvaro Sanz Rubiales1, María Luisa Del Valle Rivero2, Lucía Mateo Otero3

  • 1Hospital Universitario del Río Hortega. Valladolid. asrubiales@hotmail.com.

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica
|December 24, 2025
PubMed
まとめ
この要約は機械生成です。

エマニュエル教授は、生活の質と家族の負担を理由に、75歳以降は緩和ケア以外の治療を拒否するだろう。彼の決断は毅然としているが、終末期医療における功利主義と個人主義に関する生命倫理学的な疑問を提起する。

キーワード:
終末期医療生命倫理生活の質功利主義個人主義高齢者

さらに関連する動画

Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

35.4K
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.3K

関連する実験動画

Last Updated: Jan 8, 2026

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
10:08

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans

Published on: May 18, 2022

3.9K
Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

35.4K
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.3K

科学分野:

  • 生命倫理学
  • 医療倫理
  • 老年医学

背景:

  • 生命倫理学の専門家であるエゼキエル・J・エマニュエル教授は、75歳以降は緩和ケア以外の医療を拒否する予定である。
  • この決断は、生活の質、家族への負担、そして死についての明晰な考察を望むという懸念に基づいている。

研究 の 目的:

  • エマニュエル教授の終末期医療拒否に関する倫理的立場を分析する。
  • 彼の決断の生命倫理学的な意味合いと潜在的な解釈を探る。

主な方法:

  • 治療拒否に関するエマニュエル教授の表明された正当化の質的分析。
  • 彼の決断の功利主義的および個人主義的な側面を評価するための倫理的枠組みの適用。

主要な成果:

  • エマニュエルの議論は、延命が生活の質と同一ではないこと、家族への負担、そして明晰さをもって死に直面することに焦点を当てている。この決断は、個人を能力によって評価する功利主義的、そして主観的な認識に基づく個人主義的なものと見なすことができる。
  • Emanuel's arguments focus on life extension not equating to quality of life, the burden on families, and facing death with lucidity. The decision can be viewed as utilitarian, assessing individuals by capabilities, and individualistic, based on subjective perception.

結論:

  • エマニュエル教授の毅然とした決断は、生命倫理学における考えさせられるケーススタディを提示する。
  • 彼の考えは、生命倫理学プログラムにおける議論や教育のための貴重なツールとして役立ち、終末期医療の選択に関する議論を促す。